We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+6.02%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.37B
AUM Growth
+$453M
Cap. Flow
+$337M
Cap. Flow %
14.21%
Top 10 Hldgs %
52.25%
Holding
309
New
28
Increased
109
Reduced
121
Closed
12

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$147M
2
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$76.7M
3
SUB icon
iShares Short-Term National Muni Bond ETF
SUB
+$65.1M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$57.7M
5
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$35.6M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$75M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$20.3M
3
TER icon
Teradyne
TER
+$10.5M
4
CIEN icon
Ciena
CIEN
+$8.25M
5
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$6.7M

Sector Composition

Rank Sector Weight
1 Technology 10.08%
2 Healthcare 7.83%
3 Financials 5.02%
4 Industrials 4.83%
5 Consumer Discretionary 2.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FBIN icon
251
Fortune Brands Innovations
FBIN
$6.1B
$250K 0.01%
4,373
-743
-15% -$39.1K
GLO
252
Clough Global Opportunities Fund
GLO
$252M
$247K 0.01%
48,776
– –
KMI icon
253
Kinder Morgan
KMI
$70.2B
$243K 0.01%
13,431
-394
-3% -$7.09K
TER icon
254
Teradyne
TER
$56.1B
$241K 0.01%
2,754
-121,951
-98% -$10.5M
VLO icon
255
Valero Energy
VLO
$89B
$240K 0.01%
1,894
– –
IWS icon
256
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$233K 0.01%
2,207
+5
+0.2% +$524
ITOT icon
257
iShares Core S&P Total US Stock Market ETF
ITOT
$95.6B
$231K 0.01%
2,721
-2,186
-45% -$187K
OXY icon
258
Occidental Petroleum
OXY
$55.3B
$229K 0.01%
3,638
+49
+1% +$3.34K
A icon
259
Agilent Technologies
A
$39.2B
$225K 0.01%
+1,504
New +$215K
GD icon
260
General Dynamics
GD
$103B
$224K 0.01%
+901
New +$220K
AMT icon
261
American Tower
AMT
$80.6B
$220K 0.01%
1,038
-21
-2% -$4.37K
ELV icon
262
Elevance Health
ELV
$81.9B
$220K 0.01%
428
-63
-13% -$32K
MCK icon
263
McKesson
MCK
$99.5B
$217K 0.01%
+580
New +$216K
LIN icon
264
Linde
LIN
$221B
$214K 0.01%
+657
New +$206K
SCHV
265
Schwab US Large-Cap Value ETF
SCHV
$15.7B
$212K 0.01%
9,612
-9,210
-49% -$199K
DD icon
266
DuPont de Nemours
DD
$18.8B
$211K 0.01%
+2,444
New +$195K
ADMA icon
267
ADMA Biologics
ADMA
$2B
$207K 0.01%
53,314
– –
EXC icon
268
Exelon
EXC
$46.9B
$204K 0.01%
+4,724
New +$187K
HBAN icon
269
Huntington Bancshares
HBAN
$34.8B
$188K 0.01%
13,305
– –
CLM icon
270
Cornerstone Strategic Value Fund
CLM
$2.22B
$168K 0.01%
23,217
+1,561
+7% +$12.6K
VLY icon
271
Valley National Bancorp
VLY
$7.96B
$164K 0.01%
14,500
– –
GBDC icon
272
Golub Capital BDC
GBDC
$3.42B
$157K 0.01%
+11,901
New +$157K
INVA icon
273
Innoviva
INVA
$1.53B
$148K 0.01%
11,134
-101
-0.9% -$1.33K
OCSL icon
274
Oaktree Specialty Lending
OCSL
$1.04B
$142K 0.01%
+6,876
New +$138K
MRNS
275
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$138K 0.01%
34,629
– –
8 9 10
11
12

Similar funds

DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Grimes & Company's Q4 2022 Portfolio in Review

As of Q4 2022, Grimes & Company held 309 positions worth $2.37B, up 24% from $1.92B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Grimes & Company deployed $337M of net new capital in Q4 2022, opening 28 new positions and adding to 109 existing holdings. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 1,968,274 shares worth $148M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 12% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $75M trimmed.

  • Grimes & Company's largest Q4 2022 buy was Vanguard Short-Term Corporate Bond ETF: 1,968,274 shares worth $148M.
  • Grimes & Company added most to iShares 0-1 Year Treasury Bond ETF in Q4 2022, an estimated $76.7M increase.
  • Grimes & Company's biggest Q4 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $75M.
  • Grimes & Company fully exited First Trust Enhanced Short Maturity ETF in Q4 2022, selling an estimated $2.63M.
  • Grimes & Company's ten largest holdings make up 52% of its $2.37B portfolio in Q4 2022.
  • Grimes & Company opened 28 new positions and closed 12 in Q4 2022.
  • Grimes & Company's portfolio value rose 24% quarter-over-quarter to $2.37B.

Based on Grimes & Company's 13F filing for Q4 2022, filed 25 Jan 2023.